Articles

Zosano Pharma Articles

September 2, 2021BenzingaNews

Zosano Pharma to Present at the H.C. Wainwright Virtual Global Investment Conference

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinic... See more »
August 10, 2021GlobeNewswirePress Release

Zosano Pharma Reports Second Quarter 2021 Financial Results

FREMONT, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
July 20, 2021BenzingaNews

Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the Acute Treatment of Migraine

FREMONT, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
July 19, 2021MarketScreenerNews

Corporate Presentation July 2021

(marketscreener.com) Corporate Presentation July 2021 Copyright © 2021 Zosano Pharma Inc. | Confident... See more »
June 21, 2021MarketScreenerNews

Corporate Presentation June 2021

(marketscreener.com) Corporate Presentation June 2021 Copyright © 2021 Zosano Pharma Inc. | Confident... See more »
May 27, 2021BenzingaNews

Why Zosano Pharma's Stock Is Trading Higher Today

Zosano Pharma (NASDAQ:ZSAN) shares are trading higher after the company announced publication of clin... See more »
May 26, 2021GlobeNewswirePress Release

Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta for the Treatment of Acute Migraine in The Journal of Headache and Pain

FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical... See more »
May 14, 2021MarketScreenerNews

Reports First Quarter 2021 Financial Results (Form 8-K)

(marketscreener.com) Zosano Pharma Reports First Quarter 2021 Financial Results FREMONT, Calif., May ... See more »
May 12, 2021Seeking AlphaNews

Zosano Pharma EPS in-line

April 27, 2021FiercePharmaNews

Zosano plots 2021 resubmission for once-rejected migraine patch

Zosano plots 2021 resubmission for once-rejected migraine patch ntaylor Tue, 04/27/2021 - 05:36... See more »
April 26, 2021GlobalNewswirePress Release

Zosano Pharma Confirms Plan to Move Forward with Pharmacokinetic Study Following Protocol Review by FDA

- Company Establishes Agreement with Worldwide Clinical Trials to Conduct PK Study -... See more »
March 11, 2021MarketScreenerNews

Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results

(marketscreener.com) FREMONT, Calif., March 11, 2021 -- Zosano Pharma Corporation , a clinical-stage ... See more »
March 10, 2021StreetInsiderPress Release

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zillow Group and Zosano Pharma and Encourages Investors to Contact the Firm

NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized sha... See more »
March 2, 2021GlobalNewswirePress Release

Zosano Pharma to Present at the H.C. Wainwright Global Life Sciences Conference

FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinic... See more »
February 1, 2021GlobalNewswirePress Release

Zosano Pharma Presents Early-Onset of Action Data for Qtrypta in Acute Treatment of Migraines

FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
February 1, 2021GlobalNewswirePress Release

Zosano Pharma Announces NDA Resubmission Plans Following Type A Meeting with FDA

FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
December 1, 2020GlobalNewswirePress Release

Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm

NEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC ... See more »
November 20, 2020GlobalNewswirePress Release

Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors tha... See more »
September 3, 2020GlobeNewswirePress Release

Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference

FREMONT, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinic... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...